Hannah Ellison Team Janssen Oncology

Hannah Ellison first became aware of MMRF’s work when she was a new product manager at Janssen Oncology, and she is honored to have the opportunity to join Team Janssen on the Road to Victories this year. She is thrilled to be able to support Team Janssen and MMRF’s work to continue to bring new treatment options to patients and ensure that each and every patient has access to the evolving standard of care. While Hannah has loved leisurely biking for years, this will be her biggest test, and she draws her inspiration from the patients, caregivers, and providers who are on the frontlines of fighting myeloma every day.

Sorry, there are no posts from this member.
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit www.themmrf.org.

Learn More

At Janssen, we’re creating a future where disease is a thing of the past. We’re the Pharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access with ingenuity, and healing hopelessness with heart. We focus on areas of medicine where we can make the biggest difference: Cardiovascular, Metabolism & Retina; Immunology; Infectious Diseases & Vaccines; Neuroscience; Oncology; and Pulmonary Hypertension.

About Janssen Oncology